Fill 1 Return To RT

Through Their Eyes: What ECPs Want Most for Their GA Patients

Table of Contents

Through Their Eyes: What ECPs Want Most for Their GA Patients

Christopher D. Riemann, MD
Through Their Eyes: What ECPs Want Most for Their GA Patients image
Through Their Eyes: What ECPs Want Most for Their GA Patients image

 Supplied and Sponsored by Astellas
For U.S. ECPs Only
  Dr. Riemann is a paid spokesperson 

March 2026 Insert | Through Their Eyes: What ECPs Want Most for Their GA Patients

Through Their Eyes: What ECPs Want Most for Their GA Patients

Christopher D. Riemann, MD

Christopher Riemann Headshot

Share:

Through Their Eyes: What ECPs Want Most for Their GA Patients

Christopher Riemann Headshot

Christopher D. Riemann, MD

Vitreoretinal Surgeon, Cincinnati Eye Institute, Cincinnati
Vitreoretinal Fellowship Director, Cincinnati Eye Institute and University of Cincinnati, Cincinnati
Volunteer Associate Professor, University of Cincinnati School of Medicine, Cincinnati
Financial disclosure: Board of Trustees/Directors (Cincinnati Association for the Blind and Visually Impaired, Clovernook Center for the Blind and Visually Impaired, ForwardVue Pharma); Cofounder (Iamc2, VEO, VitaPixel); Consultant/Scientific Advisor/Speaker (AI:ON Health, ANI, Animal Eye Institute, Aniridia, Aspicio Therapeutics, Astellas, Bausch + Lomb, BMC/Eyetube, Carl Zeiss Meditec, CSTLII, DORC, Genentech/Roche, Gore, Gyroscope, Haag Streit, Iamc2, iVeena, Kaleidoscope Engineering, Lineage/BioTime, MedOne, Novartis, Reliance Industries, Vortex Surgical); Investor (iVeena, Oculinea); Medical Director (Neuracle); Royalties (MedOne, Vortex Surgical); Ownership (Digital Surgery Systems, Northmark Pharmacy, VEO, VitaPixel); Stock (AI:ON Health, Aspicio Therapeutics, CVP Clinical Governance Board ECP, Digital Surgery Systems, ForwardVue Pharma, iVeena, Oculinea, Vortex Surgical)